loading page

A Prospective Study of Social Competence in Survivors of Pediatric Brain Tumors
  • +1
  • May Albee,
  • Santiago Allende,
  • Victoria Cosgrove,
  • Matthew Hocking
May Albee
The Children's Hospital of Philadelphia

Corresponding Author:[email protected]

Author Profile
Santiago Allende
Stanford University School of Medicine
Author Profile
Victoria Cosgrove
Stanford University School of Medicine
Author Profile
Matthew Hocking
The Children's Hospital of Philadelphia
Author Profile

Abstract

BACKGROUND/OBJECTIVES: Survivors of pediatric brain tumors (BT) are at increased risk for difficulties with social competence, including poor social information processing (SIP) and peer relationships. Due to improved survival rates among BT, there is a need to better understand these challenges and if they are specific to BT versus other survivors of childhood cancer. METHODS: 51 BT and 34 survivors of pediatric solid tumors (ST) completed evaluations of SIP and peer relationship quality within 6 months of completing treatment and at one year follow-up. Caregivers also completed a measure of social skills. Linear mixed models evaluated (1) differences between BT and ST on SIP and social skills and (2) how indices of SIP were associated with peer relationships over time for ST and BT. RESULTS: BT did not differ from ST on indices of SIP or social skills over time. There was a three-way interaction between measures of SIP, group, and time to predict peer relationships. ST showed a positive association between baseline social skills and theory of mind and peer relationships over time, whereas BT showed an inverse association between baseline social skills and theory of mind and peer relationships over time. CONCLUSION: Baseline SIP and social skills affected the trajectory of BT peer relationships. BT social functioning should be monitored regularly after the completion of treatment to determine if and when intervention services would be beneficial.
23 Nov 2021Submission Checks Completed
23 Nov 2021Assigned to Editor
23 Nov 2021Submitted to Pediatric Blood & Cancer
29 Nov 2021Reviewer(s) Assigned
21 Dec 2021Review(s) Completed, Editorial Evaluation Pending
23 Dec 2021Editorial Decision: Revise Major
02 Feb 20221st Revision Received
02 Feb 2022Submission Checks Completed
02 Feb 2022Assigned to Editor
03 Feb 2022Reviewer(s) Assigned
19 Feb 2022Review(s) Completed, Editorial Evaluation Pending
22 Feb 2022Editorial Decision: Revise Minor
24 Feb 20222nd Revision Received
24 Feb 2022Submission Checks Completed
24 Feb 2022Assigned to Editor
25 Feb 2022Review(s) Completed, Editorial Evaluation Pending
26 Feb 2022Editorial Decision: Accept